Company Short-Term Debts: aptorumgroup.com (APM)

aptorumgroup.com (APM) - corporate logo

Aptorum Group Limited relies on patents in the field of orphan diseases and AI diagnostics. GURU.Markets clearly illustrates the amount of short-term financial debt, with the metric currently standing at 0.00. However, the lack of internal cash flow and dependence on external financing create risks, which are further exacerbated by the complexity of global coordination for raw material supplies used in biopharmaceutical research.

Company Short-Term Loans and Borrowings: Aptorum Group Limited (APM) for 07/04/2022 - 07/20/2026

Summary analytical data breakdowns for Aptorum Group Ltd (APM)

- price and consensus price forecast:
Price Chart Aptorum|APM - Consensus Target
- market capitalization data:
Market Capitalization Aptorum Group Limited|APM - Enterprise Value
- book capitalization data:
Accounting Value per Share Aptorum Group|APM - Accounting Value of Company|Market Value to Book Value Ratio aptorumgroup.com|APM - Company Assets
- debt and liquidity data:
Total Debt to Equity Ratio Aptorum Group Limited|APM - Long-Term Loans to Capital Ratio|Short-Term Debt to Capital Aptorum|APM - Aggregate Debt Obligations|Debts to Book Capitalization Aptorum Group Limited|APM - Long-Term Debt|Company Short-Term Debt Aptorum Group
Analysis of all company metrics:aptorumgroup.com, APM
Original product of Aptorum Group Ltd

Short-term debts reflect the aggregate of obligations with a maturity of up to one year, measuring the company's ability to service current payments without raising emergency capital. For Aptorum Group Limited (APM), with its capital-intensive development portfolio in oncology and infectious diseases, the value of short-term debt serves as a liquidity indicator, allowing for an assessment of the risk of a cash gap when financing parallel clinical trials.

Competitor analysis for Aptorum Group Limited

HLN: Company Short-Term Debt|KVUE - Company Current Liabilities|VRNA: Company Short-Term Debts|Company Short-Term Debts Jyong Bio|LGND - Company Current Liabilities|Company Short-Term Loans and Borrowings AMRX|Perrigo - Company Short-Term Debt|Short-Term Debt Alvotech S.A. ALVO|Company Current Liabilities Liquidia Technologies (LQDA)|Amount of Current Liabilities Galapagos Corp GLPG|Company Short-Term Debts ANI Pharmaceuticals (ANIP)|MNKD - Company Short-Term Loans and Borrowings|Company Short-Term Debts AMPH|PCRX (Pacira Pharmaceuticals) - Short-Term Debt|SPRY - Company Short-Term Debt|Company Short-Term Loans and Borrowings Theravance Corp|Company Short-Term Debts AQST|Company Short-Term Debts SCPH (scpharmaceuticals.com)|Tectonic Therapeutic (TECX) - Company Short-Term Debt|TNXP - Current Liabilities|Company Current Liabilities SXT China SXTC|EPRX: Amount of Current Liabilities|Company Short-Term Debt BHST|EXOZ (invizyne.com) - Short-Term Debt|ORMP - Company Short-Term Debt|Company Short-Term Loans and Borrowings Entera Bio Corp (ENTX)|Company Current Liabilities HYFT|Company Short-Term Debts ABVC (ABVC BioPharma, Inc)|Cumberland Pharmaceuticals - Company Short-Term Debt|QNTM - Company Current Liabilities|Company Current Liabilities FibroGen (FGEN)|TELO - Company Short-Term Loans and Borrowings|Company Short-Term Debts RANI (ranitherapeutics.com)|SNYR (Synergy CHC) - Short-Term Indebtedness|RLYB - Company Short-Term Debt|Company Short-Term Loans and Borrowings LEXX|Pulmatrix - Company Short-Term Debt|Short-Term Debt ftzy.com.cn PTHL|Company Current Liabilities LYRA (Lyra Therapeutics, Inc)|impactbiomedinc.com - Company Short-Term Debts|Company Short-Term Debt TNF Pharma|cbdMD, Inc. (YCBD) - Current Liabilities|Company Current Liabilities PainReform PRFX|CYTO (Altamira Therapeutics Ltd.) - Company Short-Term Loans and Borrowings|Company Short-Term Debt Lipella|Company Short-Term Debt OptiNose Corp|PIRS (Pieris Pharmaceuticals) - Company Short-Term Debts|Short-Term Debt Volume PROC (procapsgroup.com)|Petros Pharmaceuticals, Inc. - Company Short-Term Debt|Company Current Liabilities Qilian International Holding Group QLI|Company Short-Term Debts SLRN (ACELYRIN, Inc.)|TFF Pharmaceuticals, Inc (TFFP) - Short-Term Debt Volume